TAVR (TAVI)

JANS Article

The STS Risk Model for SAVR After TAVR

September 10, 2026 | Shrikar Modukuri

This study developed and validated an updated Society of Thoracic Surgeons (STS) risk model for surgical aortic valve replacement after a failed transcatheter aortic valve replacement (SAVR-after-TAVR), including the emergent and concomitant-procedure cases that earlier...

Podcast

The Beat With Joel Dunning Ep. 174: Surgical Treatment of Atrial Fibrillation

September 17, 2026 | Joel DunningGold ContributorSilver Commentor…

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with James Cox, Professor of Cardiac Surgery at the Feinberg School of Medicine at Northwestern Medicine in Chicago, Illinois, USA,...

Podcast

The Beat With Joel Dunning Ep. 173: Uniportal Robotics in the UAE

September 10, 2026 | Joel DunningGold ContributorSilver Commentor

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Taj Mohammed Fiyaz Chowdhry, a consultant thoracic surgeon at Burjeel Specialty Hospital, Sharjah, UAE, about uniportal robotics in the...

JANS Article

The STS Risk Model for SAVR After TAVR

September 10, 2026 | Shrikar Modukuri

This study developed and validated an updated Society of Thoracic Surgeons (STS) risk model for surgical aortic valve replacement after a failed transcatheter aortic valve replacement (SAVR-after-TAVR), including the emergent...

Video

ISMICS 2026 | Updates on Complex Cardiac Surgical Interventions

August 20, 2026 | Danny Ramzy…

This cardiac session features leading surgeons providing updates on complex cardiac surgical interventions at the International Society for Minimally Invasive Cardiothoracic Surgery Annual Scientific Meeting 2026. To begin, Danny Ramzy,...

JANS Article

Surgical Aortic Valve Replacement With Y-incision Aortic Annular Enlargement Provided Better Hemodynamics Than Transcatheter Aortic Valve Replacement

December 18, 2025 | Mujtaba MubashirGold Contributor

This comparative study evaluated outcomes between surgical aortic valve replacement with Y-incision aortic annular enlargement (SAVR with Y-AAE) vs transcatheter aortic valve replacement (TAVR) in 362 low-to-intermediate risk patients with...

JANS Article

Foundational Endovascular Concepts and Devices for Cardiac Surgeons

August 21, 2025 | Mujtaba MubashirGold Contributor

As interventional techniques continue to gain popularity in cardiothoracic surgery, familiarity and mastery of these techniques are increasingly important for trainees and early career surgeons. The authors discuss core endovascular...

JANS Article

Transcatheter Management of Left-Sided Valvular Heart Disease Following Heart Transplantation

July 24, 2025 | Mujtaba MubashirGold Contributor

With the improvement in survival rates for heart transplant recipients, cardiac valvular disease is more frequently being encountered in this group of patients. This includes conditions such as aortic stenosis...

Journal

The Journal of Thoracic and Cardiovascular Surgery

June 3, 2025 | Martin ANOTHER
JANS Article

Outcomes of Surgical Versus Transcatheter Aortic Valve Replacement in Patients With Low-Flow, Low-Gradient Aortic Stenosis

May 29, 2025 | Mujtaba MubashirGold Contributor

This article studied the use of both surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) in patients with low-flow, low-gradient aortic stenosis, including both classical and paradoxical...

JANS Article

Could the Age Threshold for TAVI be Relaxed to Below 65 Years? Pros and Cons

May 15, 2025 | Mateo Marin-Cuartas

Transcatheter aortic valve implantation (TAVI) has emerged as the treatment of choice for symptomatic severe aortic stenosis (AS) across the whole surgical risk spectrum. Current European guidelines recommend surgical aortic...

JANS Article

Transcatheter vs. Surgical Aortic Valve Replacement in Women: The RHEIA Trial

May 1, 2025 | Mateo Marin-Cuartas

Women with severe symptomatic aortic stenosis are underrepresented in clinical trials. The Randomized Research in Women All Comers with Aortic Stenosis (RHEIA) trial investigates the balance of benefits and risks...

JANS Article

5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis

April 24, 2025 | Mateo Marin-Cuartas

The Evolut Low Risk trial demonstrated that transcatheter aortic valve replacement (TAVR) was noninferior to surgery for the primary endpoint of all-cause mortality or disabling stroke at two years. In...

LOAD MORE
ADVERTISE ON CTSNET